UFP Technologies Inc (UFPT)
Net profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 44,924 | 41,778 | 49,624 | 46,670 | 41,789 | 36,546 | 20,795 | 16,581 | 15,886 | 16,839 | 16,038 | 13,641 | 13,369 | 14,974 | 17,627 | 19,907 | 19,750 | 18,383 | 16,876 | 16,268 |
Revenue (ttm) | US$ in thousands | 397,074 | 386,813 | 383,088 | 384,042 | 358,074 | 323,180 | 277,782 | 228,683 | 206,351 | 195,161 | 187,703 | 179,327 | 179,009 | 184,116 | 190,075 | 198,959 | 197,791 | 198,228 | 196,447 | 193,872 |
Net profit margin | 11.31% | 10.80% | 12.95% | 12.15% | 11.67% | 11.31% | 7.49% | 7.25% | 7.70% | 8.63% | 8.54% | 7.61% | 7.47% | 8.13% | 9.27% | 10.01% | 9.99% | 9.27% | 8.59% | 8.39% |
December 31, 2023 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $44,924K ÷ $397,074K
= 11.31%
The net profit margin of UFP Technologies Inc has shown some variation over the past five quarters, ranging from a low of 7.25% to a high of 12.95%. The company's net profit margin indicates that, on average, around 10% of its revenue translates into net income. The trend in net profit margin appears to be generally increasing since the beginning of 2022, reflecting improved profitability. It is essential for the company to continue monitoring and managing its expenses and revenue generation to maintain or further enhance its profitability levels in the future.
Peer comparison
Dec 31, 2023
Company name
Symbol
Net profit margin
UFP Technologies Inc
UFPT
11.31%
3M Company
MMM
-21.40%
Artivion Inc
AORT
-9.27%
Baxter International Inc
BAX
17.80%
Becton Dickinson and Company
BDX
6.44%
Boston Scientific Corp
BSX
11.39%
DexCom Inc
DXCM
15.03%
Embecta Corp
EMBC
4.95%
Glaukos Corp
GKOS
-44.41%
Globus Medical
GMED
7.83%
Haemonetics Corporation
HAE
4.53%